View Older Stories View More Recent Stories
-
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
-
Brazil asks US to spare food products, Embraer planes from 50% tariff, source says
-
GTT : First half 2025 results - Strong growth in revenue and EBITDA
-
South Africa says US pushback against domestic race policies complicating trade deal
-
Union Pacific to reshape US freight rail with $85 billion deal for Norfolk
-
Fulcrum Therapeutics reports Q2 results, pociredir trial data
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
-
Fulcrum reports positive Phase 1b trial results for sickle cell drug
-
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
UPS Releases 2Q 2025 Earnings
-
H1 2025 Results: Increase in Operating Margin & Net Cash Flow, Transformation Underway, Guidance Confirmed
-
China's industrial profits fall further in June
-
Will Nissan remain a fallen angel? Bernstein answers
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $10 at Canaccord Genuity
-
FLAGSTAR FINANCIAL, INC. REPORTS SECOND QUARTER 2025 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.19 PER DILUTED SHARE AND ADJUSTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.14 PER DILU
-
Sterling at four month low against euro as UK and euro zone rates diverge
-
US dollar rises, but on track for weekly drop ahead of Fed, BOJ
-
Eagle Hill Consulting Employee Retention Index Signals Trend for Employees Staying In Their Jobs Will Continue Over Next Six Months
-
Puma expects a loss this year due to falling sales, US tariffs
-
Intel is cutting more jobs as CEO Tan tries to fix manufacturing missteps
-
MotorK Drives Toward Profitability, Demonstrating Resilience Despite Market Challenges in H1 25
-
Canada's retail sales shrink as tariffs bite, June expected to improve
-
CTS Announces Second Quarter 2025 Results
-
Rocket Pharmaceuticals cuts workforce 30% to focus on heart treatments
-
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
-
Quarterhill Streamlines Operations to Reduce Costs and Align with Strategic Priorities
-
Mexico's Cemex posts double-digit profit rise as restructuring kicks in
-
UK factory slowdown eases but companies remain wary, CBI survey shows
-
Dow declares quarterly dividend of 35 cents per share
-
Dow reports second quarter 2025 results
-
Sterling poised to end 3-day rally vs dollar on economic, tax concerns
-
Walmart bets on AI super agents to boost e-commerce growth
-
UK firms struggle but price pressures likely to keep Bank of England on alert
-
Goldman to forgo second round of job cuts as outlook improves, FT reports
-
Australia central bank not shocked by jobless rise, to cut rates gradually
-
Retractable Technologies cuts workforce by 12.4% to save $1.6 million
-
SOUTHWEST AIRLINES REPORTS SECOND QUARTER 2025 RESULTS
-
US Supreme Court lets Trump remove consumer product safety commissioners
-
Cibus implements layoffs to reduce annual cash usage to $30M by 2026
-
Factbox-US health secretary Kennedy's vaccine actions and policy positions
-
Amazon stock target raised at BofA on expected Q2 retail beat
-
Hasbro lifts annual revenue forecast on strong demand for "Magic: The Gathering" games
-
Amazon shuts down Shanghai AI research lab, FT says
-
EnerSys cuts 575 jobs in restructuring plan to reduce costs
-
CN Announces Second Quarter Results
-
EnerSys Announces Workforce Reduction as Part of Strategic Organizational Realignment to Support Future Growth
-
German car parts maker Bosch to cut up to 1,100 jobs
-
Transitioning to Tech During the AI Frenzy? Yellow Tail Tech Makes It Possible
-
U.S. Home Prices Edge Down 0.1% in June, With Declines in Most Major Metros
-
New Report from Abnormal AI Shows Universal Alignment on AI as the Future of the SOC
